ADDC Webinar Series on Bioentrepreneurship: “Cell Therapy” (biotech)
Join us for breakfast, lunch, or cocktails in your local time zone for our monthly webinar series on bioentrepreneurship.
In this “Things I Wish I Knew” series, we will learn from prominent scientists, entrepreneurs, and investors about their successes, struggles, and the things they wished they knew before starting their journey.
In this webinar, Drs. Michel Sadelain and Bob Deans will focus on their experience launching companies that specialize in cellular therapies.
Dr. Sadelain is a world-renowned CAR-T expert at Memorial Sloan Kettering and is also a co-founder of Juno and more recently Mnemo Therapeutics.
Robert “Bob” Deans previously was VP of Research at Osiris Therapeutics and Athersys, specializing the allogeneic stem cell therapies, and is currently CSO of Synthego.
This Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers.
Webinars in this series:
March 4: How to Get Started
April 1: The View from Here
May 6: Applying Your Platform
June 3: Navigating Transitions
July 8: Cell Therapy
August 5: Cell-Based Imaging
September 9: Venture Funding
October 14: Regulatory Issues
November 11: Tech Transfer
December 3: Intellectual Property